Company: OTSA
Filing Date: 2025-05-23
Form Type: DRS/A
Source: 0001213900-25-047247
Chunk: 298

Company: OTSAW Ltd
Filing Date: 2025-05-23
Form: DRS/A
Chunk 298
---
 Assets that were acquired from Swisslog Healthcare. Total purchase consideration was USD 5,031,632. It consists of cash USD 1,077,281 (S$1.5 million), 36,613 ordinary share of Otsaw Technology Solutions Pte Ltd USD 2,238,590, ordinary share of Otsaw Swisslog Healthcare Robotics Pte Ltd USD 2,889 and deferred consideration USD1,594,699 (a 40% ownership). In January 2023, a deferred consideration payment of USD 97,002 and a consideration adjustment of USD486,468 were made due to revenue targets not met, resulting in recognising other income of the said amount. In January 2024, a deferred consideration payment of USD 335,648 and a consideration adjustment of USD 259,875 were made due to revenue targets not met, resulting in recognising other income of the said amount. The carrying amount of the acquired intangible assets as at April 30, 2024 was USD 3,189,072 (2023: USD 3,970,625).

|                        |     |      2024 |     |      2023 |
|                        |     |       USD |     |       USD |
| Favourable rights      |     |    73,281 |     |   202,961 |
| Contract backlogs      |     |         — |     |   113,508 |
| Customer relationships |     | 2,484,694 |     | 2,869,690 |
| Intellectual property  |     |   631,097 |     |   784,466 |
| Total (Note 11)        |     | 3,189,072 |     | 3,970,625 |

17.Other reserves Currency translation reserve The currency translation reserve comprises foreign exchange differences arising from the translation of the financial statements of foreign operations whose functional currencies are different from the presentation currency of the Group. Capital reserve The capital reserve comprises Issuance of ordinary shares by a subsidiary, and contributed surplus and the repurchase of shares in subsidiary from minority interest shareholders.

F-31

OTSAW LIMITED AND ITS SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 30 APRIL 2024 18.Trade and other payables

|                                          |     |      2024 |     |      2023 |   |
|